This is a non-core endpoint: only basic statistics are computed.
Melanocytic naevi of lip
CD2_BENIGN_MELANOCYTIC_LIP_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus (cutis) labii (oris)
Melanocytic naevi of lip
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 314 | 237 | 77 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.03 |
| Median age at first event (years) | 43.83 | 42.12 | 49.11 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 291
- Matched controls
- 2908
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D22.0
ICD-10 Finland
Melanocytic naevi of lip
4503599627370496.0
323.0
264
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
18.7
46.2
73
51
2160A
ICD-9 Finland
Benign neoplasm of skin, Skin of lip[HUULEN IHON BENIGNI KASVAIN,NAEVUS PIGMENTOSUS]
+∞
28.6
27
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
25.4
24
*
115
Kela drug reimbursment
Breast cancer
+∞
24.3
23
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
9.4
22.6
48
60
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
11.0
22.2
43
45
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
17.9
17
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.1
17.7
50
95
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
24.8
16.7
23
10
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
8.1
16.7
38
53
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
15.8
15
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
15.8
15
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
30.5
15.4
20
7
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
14.7
14
*
H02AB02
ATC
dexamethasone; systemic
19.4
13.6
20
11
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
67.8
11.7
13
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.9
11.2
25
34
EAA10
NOMESCO Finland
Excision of lesion of lip
22.5
10.8
15
7
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.1
10.8
29
52
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
12.7
10.5
18
15
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
9.3
10.5
21
24
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
10.6
10.2
19
19
9733
FHL
Excision of skin change in operating room or anesthesia
12.8
10.0
17
14
L02BA01
ATC
tamoxifen; oral
103.3
9.5
10
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.4
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
9.4
9
*
130
Kela drug reimbursment
Malignant tumour
+∞
9.4
9
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
9.4
9
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
9.4
9
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
8.4
8
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.4
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.4
8
*
HA1AA
NOMESCO Finland
X-ray mammography
6.2
8.2
21
36
XQ848
NOMESCO Finland
Dermatological photography
10.4
7.6
14
14
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
5.6
7.5
21
40
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
+∞
7.3
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
XQ845
NOMESCO Finland
Dermatoscopy
20.6
7.2
10
5
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
6.7
87
489
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
12.6
6.6
11
9
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
7.7
6.5
14
19
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
71.4
6.5
7
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
6.4
50
221
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
L02BG03
ATC
anastrozole; oral
+∞
6.3
6
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
+∞
6.3
6
*
L02BG04
ATC
letrozole; oral
5.8
6.1
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
141
831
2.26
11.17
2.5
1.7
—
—
—
0
0
(4035726)
27
64
4.52
10.79
1.5
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
24
6.51
9.07
1.3
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
34
110
3.34
8.82
3.4
1.6
ug/l
2.2
5.2
0.58
29
83
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
55
267
2.29
6.55
3.1
2.4
%
23.8
24.2
0.08
48
231
(3002256) Pathology report gross observation
45
200
2.46
6.53
1.5
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
128
911
1.68
4.70
3.7
3.5
g/l
36.8
36.4
0.32
122
845
(3013650) Neutrophils [#/volume] in Blood by Automated count
172
1342
1.62
4.27
9.8
6.2
e9/l
4.2
4.1
0.03
149
1157
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
151
1154
1.59
4.00
5.5
3.6
umol/l
12.3
10.6
0.75
145
1074
(42870588) Differential panel, method unspecified - Blood
110
780
1.63
3.96
5.4
4.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
54
325
1.80
3.51
2.7
2.5
e6/l
2.1
3.5
0.75
24
157
(3013115) Eosinophils [#/volume] in Blood
160
1276
1.52
3.30
6.3
5.2
e9/l
0.2
0.2
0.69
140
1115
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
213
1819
1.53
3.08
7.6
5.2
u/l
76.3
73.8
0.35
199
1686
(3001604) Monocytes [#/volume] in Blood
153
1224
1.49
3.02
6.4
4.9
e9/l
0.5
0.6
0.72
130
1055
(3006315) Basophils [#/volume] in Blood
153
1229
1.48
2.93
6.3
4.9
e9/l
0.0
0.0
0.04
131
1058
(3007853) Bacteria identified in Skin by Aerobe culture
41
243
1.79
2.81
2.3
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
6
8.44
2.76
1.2
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
6
8.44
2.76
1.2
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
137
1088
1.46
2.73
6.7
5.0
%
0.7
0.7
0.05
126
998
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
86
2.29
2.69
5.7
13.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
154
1253
1.45
2.69
6.4
5.0
e9/l
2.0
1.9
0.33
138
1097
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
107
812
1.48
2.68
3.4
2.5
u/l
30.4
29.4
0.20
100
779
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
43
263
1.74
2.65
1.7
2.3
umol/l
7.1
5.9
0.37
37
218
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
139
1112
1.45
2.64
6.7
5.3
mmol/l
1.2
1.2
0.12
119
940
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
121
2.06
2.63
1.5
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
98
734
1.49
2.61
3.1
2.9
mmol/l
6.7
7.4
0.66
80
623
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
44
2.80
2.57
1.2
1.0
u/ml
0.1
1.4
—
7
15
(1761868) Lipid panel - Serum or Plasma
78
1047
0.66
2.57
3.1
2.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
7
7.24
2.56
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
33
3.10
2.55
1.1
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
222
1947
1.48
2.54
4.1
3.9
mm/h
12.2
10.7
0.70
208
1802
(3037467) Urinalysis macro (dipstick) panel - Urine
204
1762
1.45
2.51
4.6
4.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
88
658
1.47
2.33
3.2
3.1
mg/l
2351.4
262.0
0.93
53
404
(3020682) Albumin/Creatinine [Ratio] in Urine
92
697
1.45
2.27
3.9
3.9
mg/mmol
9.3
8.9
0.03
57
417
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
27
153
1.84
2.16
1.3
2.1
g/l
0.2
0.2
0.54
27
138
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
53
362
1.56
2.14
2.5
2.4
e6/l
0.8
1.2
0.54
23
195
(3006504) Eosinophils/100 leukocytes in Blood
138
1136
1.38
2.11
6.7
4.9
%
3.2
2.9
0.69
127
1048
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
10
5.06
2.08
1.0
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
119
962
1.38
2.01
2.0
1.9
pmol/l
98.4
96.2
0.17
54
479
(3019069) Monocytes/100 leukocytes in Blood
138
1143
1.37
2.00
6.8
5.2
%
8.2
8.1
0.12
128
1063
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
77
2.14
2.00
1.3
1.2
g/l
6.9
7.5
—
10
60
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
77
2.14
2.00
1.3
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
77
2.14
2.00
1.3
1.2
g/l
3.4
3.9
—
10
58
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
78
586
1.44
2.00
2.3
2.1
mg/l
2.8
3.1
0.63
67
492
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
66
2.17
1.85
1.6
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
12
4.22
1.83
2.6
2.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
87
677
1.39
1.82
2.2
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
132
1099
1.35
1.81
5.0
3.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
139
1168
1.34
1.79
6.7
5.0
%
28.5
28.9
0.21
128
1083
(3019550) Sodium [Moles/volume] in Serum or Plasma
277
2598
1.56
1.78
16.5
12.2
mmol/l
139.4
139.7
1.25
270
2519
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
121
999
1.34
1.74
5.8
5.1
mmol/l
1.2
1.2
0.25
109
898
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
13
3.89
1.72
1.2
1.7
—
—
—
0
0
(4281824)
5
13
3.89
1.72
1.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
13
3.89
1.72
2.0
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
19
104
1.88
1.71
1.5
1.5
miu/ml
196.9
232.7
0.21
11
55
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
12
55
2.23
1.69
1.2
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
42
2.43
1.69
1.5
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
137
1157
1.33
1.68
6.5
4.8
%
58.0
56.9
0.62
127
1079
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
76
2.02
1.67
1.2
1.2
g/l
3.1
3.0
—
10
59
(3023323) Follitropin [Units/volume] in Serum or Plasma
22
128
1.77
1.65
1.2
1.2
iu/l
27.0
24.9
0.10
22
109
(3042936) Bacteria identified in Isolate by Culture
41
282
1.52
1.63
2.4
2.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
92
736
1.35
1.61
3.1
1.9
mmol/l
2.4
2.4
0.54
85
636
(3003396) Base excess in Arterial blood by calculation
33
217
1.58
1.59
4.7
8.6
mmol/l
1.5
1.5
0.01
23
173
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
1.2
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
91
729
1.35
1.58
3.4
2.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
276
2603
1.50
1.54
17.2
12.3
mmol/l
3.9
3.9
0.03
270
2518
(40758558) Short blood count panel - Blood
72
558
1.38
1.53
8.0
5.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
77
605
1.36
1.51
3.3
2.6
e6/l
0.8
0.5
0.68
52
446
(3026782) Osmolality of Urine
57
429
1.40
1.44
4.1
2.1
mosm/kgh2o
547.0
553.7
0.07
45
356
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
92
748
1.33
1.43
2.0
2.2
u/l
53.4
55.8
0.39
86
695
(3018095) Leukocytes [#/volume] in Urine
100
823
1.32
1.43
3.9
3.2
e6/l
114.0
104.0
0.06
64
551
(3052851) Hemolysis interference index of Serum or Plasma
13
67
1.98
1.40
4.0
2.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
82
663
1.32
1.32
3.5
2.7
e6/l
48.6
146.4
0.47
58
503
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
29
194
1.55
1.32
2.6
1.8
ml/min/173m2
68.5
67.9
0.03
12
77
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
32
219
1.51
1.32
4.8
8.5
kpa
5.4
5.2
0.29
27
212
(3027801) Oxygen [Partial pressure] in Arterial blood
32
219
1.51
1.32
4.8
8.5
kpa
12.4
12.0
0.11
27
212
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
124
1060
1.28
1.32
2.2
2.3
nmol/l
80.2
77.2
0.73
113
951
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
227
2092
1.31
1.32
4.5
4.1
pmol/l
14.5
14.6
0.09
208
1932
(3037522) Nuclear Ab [Titer] in Serum
50
375
1.40
1.30
1.6
1.4
titre
250.0
601.3
2.45
12
92
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
44
2.08
1.28
2.2
3.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
239
2224
1.31
1.25
20.0
12.7
%
13.7
13.5
0.60
234
2179
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
108
1.71
1.25
1.8
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
129
1115
1.27
1.24
11.6
7.1
e9/l
0.0
0.0
0.12
99
909
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
74
597
1.31
1.21
2.6
2.9
ng/l
2962.5
1224.5
0.38
63
498
(3019060) Gas panel - Arterial blood
19
117
1.66
1.21
3.8
8.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
26
2.33
1.19
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
32
225
1.47
1.18
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
72
1.84
1.17
1.4
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
39
2.08
1.16
1.1
1.2
—
—
—
0
0
(44813793)
5
20
2.52
1.15
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
287
2756
1.48
1.15
11.5
8.2
u/l
25.8
24.8
0.58
279
2660
(3037756) Immunofixation for Serum or Plasma
7
30
2.36
1.13
1.3
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
261
2470
1.34
1.12
5.6
4.8
mu/l
1.9
2.3
0.42
246
2287
(40768797) Stomach Pathology biopsy report
44
332
1.38
1.12
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
194
1.49
1.11
1.1
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
273
2602
1.38
1.11
14.8
10.5
mg/l
18.3
20.2
0.61
208
1964
(3011397) Hemoglobin [Presence] in Urine by Test strip
70
568
1.30
1.10
3.0
3.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
41
1.98
1.09
2.4
2.0
%
13.8
13.2
—
8
41
(3001019) Free T4 and TSH panel - Serum or Plasma
10
179
0.54
1.09
2.0
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
32
2.21
1.08
1.6
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
31
221
1.45
1.08
2.3
2.1
u/l
32.0
29.4
0.37
24
187
(3019309) Folate [Moles/volume] in Red Blood Cells
53
416
1.33
1.05
1.6
1.7
nmol/l
1398.5
1224.5
0.37
44
312
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
122
1.59
1.05
3.4
2.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
22
2.29
1.04
1.4
1.1
—
94.4
—
0
5
(3001122) Ferritin [Mass/volume] in Serum or Plasma
140
1244
1.23
1.01
3.4
2.7
ug/l
103.9
87.4
0.64
135
1159
(3023368) Bacteria identified in Blood by Culture
60
483
1.30
1.00
7.4
3.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
40
303
1.37
1.00
1.8
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
62
503
1.29
0.98
1.3
1.3
u/ml
1.3
11.7
3.29
30
191
(3002179) Metamyelocytes/100 leukocytes in Blood
21
141
1.52
0.97
9.2
4.2
%
0.0
0.7
—
5
20
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
54
1.88
0.97
1.5
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
7
36
1.97
0.97
1.3
1.4
pmol/l
518.7
412.1
—
7
27
(36304419) Bacteria [Presence] in Urine
73
606
1.27
0.96
3.1
2.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
326
1.33
0.91
2.1
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
217
0.63
0.91
1.8
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
103
0.48
0.91
1.2
1.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
29
2.09
0.90
1.2
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
50
400
1.30
0.88
2.3
2.0
mmol/l
2.4
2.4
0.14
38
345
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
455
1.28
0.88
3.3
3.4
ng/l
410.6
122.2
0.76
40
313
(3013512) EKG study
77
651
1.24
0.87
3.7
3.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
145
1.48
0.87
9.8
4.3
%
0.1
0.1
—
8
25
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
30
2.02
0.87
1.2
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.2
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.2
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.2
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
30
2.02
0.87
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.2
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
187
1728
1.20
0.86
3.8
3.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
45
1.80
0.85
1.1
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
31
1.95
0.85
1.0
1.3
nmol/l
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
18
121
1.52
0.84
3.9
8.4
%
0.6
0.7
0.38
18
121
(3018418) pH of Serum or Plasma
79
673
1.23
0.84
5.0
2.9
ph
7.4
7.4
0.17
12
107
(3007461) Platelets [#/volume] in Blood
299
2916
1.53
0.83
23.9
15.8
e9/l
259.9
256.3
0.47
294
2848
(40768443) Skin Pathology biopsy report
14
89
1.60
0.82
1.4
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
23
164
1.43
0.82
2.9
2.8
e9/l
66.1
68.7
0.19
15
127
(40761511) CBC panel - Blood by Automated count
285
2758
1.36
0.82
16.0
10.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
299
2918
1.52
0.80
23.8
15.7
pg
30.1
30.1
0.26
294
2872
(3024731) MCV [Entitic volume]
299
2918
1.52
0.80
23.8
15.8
fl
90.4
90.5
0.23
294
2872
(3007164) IgA [Mass/volume] in Serum or Plasma
67
564
1.24
0.79
1.4
1.3
g/l
2.1
2.3
0.45
39
333
(3040151) Glucose [Moles/volume] in Capillary blood
0
25
0.00
0.79
0.0
12.7
—
6.6
—
0
17
(3026361) Erythrocytes [#/volume] in Blood
299
2919
1.51
0.79
23.9
15.8
e12/l
4.5
4.5
0.99
293
2843
(3010813) Leukocytes [#/volume] in Blood
299
2920
1.50
0.77
23.9
15.8
e9/l
6.8
6.6
0.89
293
2844
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
50
408
1.27
0.77
1.9
2.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
18
124
1.48
0.77
3.9
8.2
%
1.5
1.6
0.06
18
124
(3032080) INR in Blood by Coagulation assay
96
842
1.20
0.76
12.2
7.9
inr
1.3
1.2
0.39
27
249
(3000963) Hemoglobin [Mass/volume] in Blood
299
2921
1.49
0.76
24.0
15.9
g/l
133.6
135.3
1.66
294
2874
(3049717) Cytology report of Urine Cyto stain
9
54
1.69
0.75
2.4
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
125
1.47
0.74
1.6
2.3
u/l
9155.7
2358.3
—
5
49
(3017181) Myelocytes/100 leukocytes in Blood
21
151
1.42
0.73
9.8
4.2
%
0.4
0.9
—
8
28
(3024354) Oxygen [Partial pressure] in Venous blood
22
160
1.40
0.72
3.5
2.3
kpa
5.5
4.6
0.74
22
155
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
89
779
1.20
0.72
3.2
2.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
45
366
1.27
0.72
2.0
2.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
15
101
1.51
0.71
1.3
1.7
—
10.9
—
0
5
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
26
1.94
0.71
3.2
4.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
12
180
0.65
0.70
3.2
3.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
10
61
1.66
0.69
1.3
2.4
mg/l
9.1
10.9
—
10
55
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
27
1.87
0.68
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
13
86
1.53
0.67
1.3
1.8
—
154.3
—
0
7
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
75
651
1.20
0.66
1.3
1.3
u/ml
0.6
2.1
1.34
19
179
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
103
1.48
0.66
2.5
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
87
1.52
0.64
1.3
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
11
71
1.57
0.63
1.5
2.6
g/l
0.3
0.4
—
6
18
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
81
712
1.19
0.63
2.2
1.9
u/l
226.4
245.8
0.06
76
679
(4010399)
24
183
1.34
0.61
1.7
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
36
291
1.27
0.61
5.0
3.4
%
20.2
25.0
1.46
20
114
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
298
0.75
0.61
2.0
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
51
1.58
0.61
1.8
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
148
1368
1.15
0.61
3.8
4.3
mmol/l
6.8
6.6
0.59
129
1238
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
60
515
1.20
0.60
2.3
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
21
0.00
0.60
0.0
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
123
1.40
0.59
1.5
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
53
1.52
0.59
2.3
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
137
1262
1.15
0.58
3.6
3.4
estimate
0.0
0.0
0.00
26
232
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
1.1
—
0
12
(3021788) Differential panel - Synovial fluid
6
35
1.73
0.58
2.3
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
187
1762
1.15
0.58
3.0
2.8
u/l
47.1
40.1
0.56
178
1658
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
59
509
1.20
0.56
1.2
1.3
iu/ml
38.1
35.4
0.04
18
163
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
55
1.47
0.56
2.1
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
19
142
1.36
0.56
10.1
4.3
%
0.0
0.3
—
7
22
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
37
1.63
0.56
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
38
1.59
0.54
1.3
1.1
—
—
—
0
0
(3012544) pH of Venous blood
26
206
1.29
0.53
3.7
2.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
40
1.51
0.52
2.5
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
40
1.51
0.52
1.5
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
24
300
0.78
0.50
1.5
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
18
136
1.34
0.50
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
189
0.73
0.50
1.9
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
28
342
0.80
0.49
1.7
2.2
ug/g
61.2
121.2
1.79
19
266
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
56
489
1.18
0.48
1.8
1.7
pmol/l
496.9
29567762.8
0.78
48
416
(3021960) Folate [Moles/volume] in Serum or Plasma
65
575
1.16
0.47
1.5
1.5
nmol/l
21.5
21.3
0.06
57
489
(3019832) Treponema pallidum Ab [Presence] in Serum
30
362
0.81
0.47
1.7
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
201
1.26
0.46
3.2
2.5
ug/l
0.7
0.7
0.05
16
119
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
112
1.36
0.45
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
112
1.36
0.45
1.6
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
136
1270
1.13
0.45
5.3
4.7
estimate
0.0
0.0
0.00
27
227
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
79
872
0.87
0.45
2.9
3.3
ng/l
26.2
77.6
0.60
46
545
(3022621) pH of Urine by Test strip
12
163
0.73
0.45
2.1
2.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
63
559
1.16
0.44
1.4
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
20
157
1.29
0.44
6.6
7.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
113
1.34
0.43
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
113
1.34
0.43
1.6
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
244
2363
1.15
0.43
6.0
5.3
mmol/mol
39.3
39.1
0.13
224
2219
(3041354) Potassium [Moles/volume] in Venous blood
5
31
1.62
0.43
4.0
2.0
mmol/l
4.0
4.0
—
5
31
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
31
1.62
0.43
4.0
2.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
31
1.62
0.43
4.0
2.0
mmol/l
102.0
105.0
—
5
31
(3021901) Oxygen saturation in Capillary blood
5
31
1.62
0.43
1.8
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
8.2
1.3
—
—
—
0
0
(3015736) pH of Urine
109
1007
1.13
0.43
3.4
3.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
149
1.29
0.43
1.8
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
222
1.24
0.42
2.1
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
33
1.52
0.41
1.2
1.7
%
68.0
61.8
—
5
33
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
159
1.28
0.41
1.2
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
17
0.00
0.41
0.0
1.4
—
482296.4
—
0
11
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
8.6
2.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
104
0.67
0.40
1.3
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
224
1.22
0.40
2.3
1.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
19
0.00
0.39
0.0
1.1
—
1.0
—
0
7
(3009542) Hematocrit [Volume Fraction] of Blood
249
2421
1.14
0.38
16.7
11.7
%
39.3
40.3
0.97
181
1831
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
5
36
1.40
0.38
1.4
1.1
—
113.9
—
0
7
(3009261) Glucose [Presence] in Urine by Test strip
136
1282
1.11
0.37
3.7
3.5
estimate
0.0
0.0
0.50
25
224
(3000850) Epithelial cells [#/volume] in Urine
52
463
1.15
0.36
2.8
2.2
e6/l
5.2
8.2
0.78
40
410
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.36
2.5
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
99
1.33
0.36
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
25
209
1.21
0.35
4.4
2.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
63
570
1.13
0.35
2.9
2.2
umol/l
315.1
4972.4
2.08
51
500
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
257
2510
1.13
0.33
4.8
4.2
mmol/l
5.7
5.8
0.81
239
2307
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
191
1839
1.10
0.32
3.4
3.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
47
1.28
0.32
1.2
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
47
1.28
0.32
1.2
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
37
326
1.15
0.30
1.4
1.6
%
1.4
1.4
0.05
32
295
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
26
302
0.85
0.30
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
10
129
0.77
0.28
1.1
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
35
309
1.15
0.28
2.3
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
64
1.26
0.27
9.8
3.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
11
139
0.78
0.27
1.1
1.1
—
106.2
—
0
5
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
122
1.24
0.27
1.7
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
14
113
1.25
0.27
4.8
5.3
mmol/l
24.8
25.1
0.14
14
113
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
203
0.83
0.26
1.6
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
77
1.31
0.26
1.1
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
123
1.23
0.26
1.3
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
123
1.23
0.26
1.3
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
123
1.23
0.26
1.3
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
96
1.26
0.25
1.5
1.3
—
—
—
0
0
(3020891) Body temperature
11
87
1.27
0.24
5.8
4.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
73
681
1.09
0.24
1.7
1.7
mmol/l
1.3
1.4
0.79
61
586
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
83
0.72
0.24
1.0
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
83
0.72
0.24
1.5
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
115
1.23
0.24
1.4
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
97
1.25
0.23
1.6
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
39
1.29
0.23
1.4
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
39
1.29
0.23
3.6
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
41
1.22
0.22
1.6
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
41
1.22
0.22
1.6
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
50
461
1.10
0.21
2.0
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
42
1.19
0.21
1.2
2.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.1
—
0.7
—
0
6
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
127
1.19
0.20
6.0
2.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
99
1.22
0.20
1.6
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
62
581
1.08
0.19
1.5
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
62
659
0.93
0.18
3.9
3.7
estimate
0.0
0.0
0.00
24
224
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
245
2410
1.08
0.18
14.4
9.3
ml/min/173m2
82.8
84.1
0.42
200
1920
(3025941) Bacteria identified in Stool by Culture
17
148
1.16
0.17
1.2
1.2
—
—
—
0
0
(4094501)
5
67
0.74
0.17
1.2
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
77
733
1.07
0.16
3.4
2.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
8
73
1.10
0.16
1.8
2.1
%
85.5
92.6
—
8
65
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
78
0.76
0.15
1.0
1.2
—
39.9
—
0
7
(3027944) Amphetamines [Presence] in Urine
14
123
1.14
0.12
1.4
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
168
0.89
0.12
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
291
1.07
0.10
7.3
6.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
265
2629
1.05
0.09
5.2
4.6
mmol/l
2.7
2.8
0.65
244
2443
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
185
1.09
0.08
1.8
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
67
1.05
0.08
1.3
1.3
pmol/l
49.0
57.5
—
7
67
(3023511) Choriogonadotropin [Units/volume] in Urine
6
71
0.84
0.07
1.0
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
71
0.84
0.07
1.0
1.2
u/l
9.4
12.5
—
6
58
(3045414) Leukocytes [Presence] in Urine
12
108
1.12
0.07
1.7
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
16
147
1.09
0.07
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
112
0.89
0.07
1.4
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
85
1.06
0.07
1.2
1.3
—
3.1
—
0
13
(3036489) Thrombin time
9
86
1.05
0.07
1.7
2.0
s
20.1
20.8
—
9
72
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
88
1.02
0.07
1.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
9
88
1.02
0.07
1.2
1.3
—
12.9
—
0
18
(3003327) Ova and parasites identified in Stool by Light microscopy
11
99
1.12
0.06
3.0
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
109
1.10
0.06
1.0
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
249
2473
1.03
0.06
4.1
3.8
mmol/l
1.3
1.3
0.44
227
2287
(42529406) Shigella sp [Presence] in Stool by Culture
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
61
594
1.03
0.05
7.1
4.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
57
556
1.03
0.04
1.8
1.7
mg/l
1.1
0.9
0.49
38
417
(46235355) HIV 1 and 2 tests - Meaningful Use set
56
574
0.97
0.04
2.1
2.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
140
0.93
0.04
1.6
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
18
189
0.95
0.03
3.7
2.2
e9/l
4.1
3.9
0.23
13
149
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
258
2590
0.98
0.02
4.7
4.2
mmol/l
4.7
4.7
0.15
242
2424
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
100
992
1.01
0.01
3.9
3.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
29
283
1.03
0.01
1.6
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
287
0.97
0.01
5.1
4.3
%
32.1
32.3
0.03
18
183
(3019225) pH of Specimen
20
199
1.01
0.00
3.9
3.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
229
1.00
0.00
1.1
1.2
iu/ml
50.0
152.9
—
9
97
(40761536) Microorganisms panel - Urine sediment
21
207
1.02
0.00
2.8
3.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
237
1.01
0.00
1.7
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
24
237
1.01
0.00
1.3
2.0
nmol/l
391.1
378.7
0.11
24
216
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
258
2577
1.01
0.00
4.6
4.1
mmol/l
1.5
1.5
0.06
238
2399
(3003694) ABO and Rh group [Type] in Blood
71
707
1.01
0.00
1.6
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
26
256
1.02
0.00
1.5
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
58
576
1.01
0.00
3.8
3.7
kg/l
1.0
1.0
—
6
76
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
205.3
—
0
9
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000492) Spirometry study
24
240
1.00
0.00
1.6
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
76
0.92
0.00
1.4
3.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
65.1
—
0
8
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
15.1
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
10.8
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
1.9
—
1.2
—
0
7
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
67
0.89
0.00
2.2
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
69
0.87
0.00
1.3
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
66
0.91
0.00
1.5
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.3
—
0
6
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
69
1.01
0.00
2.3
1.8
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
1.2
—
0
5
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
89
1.01
0.00
1.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.9
—
1.2
—
0
7
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
1.7
—
0
7
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
8.1
—
0
7
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4034850)
9
89
1.01
0.00
9.7
9.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_LIP_EXALLC – Melanocytic naevi of lip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).